These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3896973)

  • 1. T cell depletion of donor marrow for prevention of acute graft-versus-host disease.
    Martin PJ; Hansen JA; Storb R; Thomas ED
    Haematol Blood Transfus; 1985; 29():42-3. PubMed ID: 3896973
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathophysiology and prevention of graft-versus-host disease.
    Storb R
    Prog Clin Biol Res; 1984; 149():337-66. PubMed ID: 6377326
    [No Abstract]   [Full Text] [Related]  

  • 3. Depletion of T cells from bone marrow grafts with soybean agglutinin and sheep red blood cells for prevention of graft-versus-host disease.
    Verdonck LF; Dekker AW; van Heugten H; van Kempen ML; Punt K; de Gast GC
    Haematol Blood Transfus; 1987; 30():563-6. PubMed ID: 3305219
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bone marrow transplantation: problems and hypotheses].
    Faĭnshteĭn FE; Liubimova LS
    Gematol Transfuziol; 1984 Apr; 29(4):3-9. PubMed ID: 6376270
    [No Abstract]   [Full Text] [Related]  

  • 5. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
    Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
    Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell depletion of HLA and haploidentical marrow reduces graft-versus-host disease but it may impair a graft-versus-leukemia effect.
    Henslee PJ; Thompson JS; Romond EH; Doukas MA; Metcalfe M; Marshall ME; MacDonald JS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2701-6. PubMed ID: 3547948
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of the microbial flora on incidence of graft-versus-host disease in human allogeneic bone marrow transplantation.
    Schmeiser T; Kurrle E; Arnold R; Heit W; Krieger D; Kubanek B; Heimpel H
    Prog Clin Biol Res; 1985; 181():433-5. PubMed ID: 3895247
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure.
    Gajewski JL; Ho WG; Feig SA; Hunt L; Kaufman N; Champlin RE
    Transplantation; 1990 Aug; 50(2):244-9. PubMed ID: 2143325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation in Brazil.
    Ferreira E; Dulley FL; Morsoletto F; Neto JZ; Pasquini R
    Hum Immunol; 1985 Nov; 14(3):324-32. PubMed ID: 3902750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vivo detection of alloreactive T cells of the donor in graft versus host disease].
    Irlé C; Kaestli M; Chapuis B; Jeannet M
    Schweiz Med Wochenschr; 1986 Nov; 116(47):1643-4. PubMed ID: 3541172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct types of donor and recipient T cell clones functionally related to host-v-graft reactivity and autologous remission after bone marrow transplantation for severe aplastic anemia.
    Schneider EM; Pawelec G; Haen M; Ehninger G; Ostendorf P; Kömpf J; Schöllhorn V; Wernet P
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2620-5. PubMed ID: 2950637
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone marrow transplantation.
    Geary CG; Evans DI; Scarffe JH
    Br J Hosp Med; 1982 Apr; 27(4):393, 395-7, 399. PubMed ID: 7042020
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased adhesion molecule expression during graft-versus-host disease.
    Kobayashi S; Hashino S; Tanaka J; Mori A; Kobayashi M; Asaka M; Imamura M
    Transplant Proc; 2000 Nov; 32(7):2452-3. PubMed ID: 11120240
    [No Abstract]   [Full Text] [Related]  

  • 14. [Transplantation of allogeneic bone marrow treated in vitro with Campath-1 monoclonal antibody].
    Chapuis B; Helg C; Maurice P; Wyss M; Pipard G; Irlé C; Jeannet M
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1521-2. PubMed ID: 3909387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic and clinical perspectives in human bone marrow transplantation.
    Gale RP; Opelz G
    Transplant Proc; 1978 Mar; 10(1):265-8. PubMed ID: 345565
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow transplantation (1958-1978) : conditioning and graft-versus-host disease, indications in aplasias and leukemias.
    Mathe G; Schwarzenberg L
    Pathol Biol (Paris); 1979 Jun; 27(6):337-43. PubMed ID: 159426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical issues in bone marrow transplantation.
    Storb R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2774-81. PubMed ID: 3547955
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune recovery after bone marrow and peripheral blood stem cells transplantation.
    Marin GH; Mendez MC; Menna ME; Malacalza J; Bergna MI; Klein G; Italiano C; Perez M; Gil MA; Gardenal L; Mansilla E; Orlando S; Saba S; Cánepa C; Piccinelli G
    Transplant Proc; 1999 Sep; 31(6):2582-4. PubMed ID: 10500728
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between HLA-B antigens and acute graft-versus-host disease.
    Storb R; Prentice RL; Hansen JA; Thomas ED
    Lancet; 1983 Oct; 2(8354):816-9. PubMed ID: 6137649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunogenetics of chronic graft versus host disease and its relevance for the graft versus leukemia effect.
    van Rood JJ; Goulmy E; van Leeuwen A
    Prog Clin Biol Res; 1987; 244():433-8. PubMed ID: 3310005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.